From Discovery to Decision: Building a Fit-for-Purpose Proteomics Strategy for Clinical Development
Late-stage clinical trial attrition remains one of the most expensive challenges in drug development, with more than half of Phase III programs failing to meet…
During normal physiological wound healing, inflammation, angiogenesis and fibrogenesis are all effectively controlled, so that once sufficient matrix has accumulated…
